Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays

The Orphan Drug Act in the Modern Drug Pricing Era

Rising stroke rates in young adults highlight urgent prevention—manage blood pressure and cholesterol early, address obesity trends, and improve outcomes through better ICU care.

Senate Democrats Outline Drug Pricing Agenda to Cut Patient Costs

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

Prescription drugs on a money banknotes. Concept of healthcare costs - Vitalii - stock.adobe.com.jpeg

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

Finance Committee leaders propose expanding Medicare negotiation, curbing middlemen, and reinvesting in biomedical innovation as part of a 2026 health care affordability strategy.

January 27th 2026

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency

Increasing Medicare Advantage payments for full Medicaid enrollees was not associated with meaningful changes in inpatient or nursing home use.

Congress advances sweeping PBM transparency reforms tied to Medicare Part D as part of a broader spending package. | Image Credit: PBMs_MQ-Illustrations.jpeg

Stroke Rates Are Rising in Younger Adults, as Older Populations See Declines: Emily R. Fisher, MD

A spending bill advancing PBM reforms aims to delink Medicare Part D compensation from drug rebates and improve pricing transparency.

Related Content

The Orphan Drug Act in the Modern Drug Pricing Era

Rising stroke rates in young adults highlight urgent prevention—manage blood pressure and cholesterol early, address obesity trends, and improve outcomes through better ICU care.

Senate Democrats Outline Drug Pricing Agenda to Cut Patient Costs

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

Finance Committee leaders propose expanding Medicare negotiation, curbing middlemen, and reinvesting in biomedical innovation as part of a 2026 health care affordability strategy.

January 27th 2026

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency

Increasing Medicare Advantage payments for full Medicaid enrollees was not associated with meaningful changes in inpatient or nursing home use.